Showing results (1-10 of 275) with videos related to
Sort By:
Pageof 28
Journal of Cardiovascular Pharmacology|August 2, 2007
Rho kinase (ROCK) inhibitorsJames K Liao, Minoru Seto, Kensuke NomaAmerican Journal of Physiology. Cell Physiology|February 14, 2006
Physiological role of ROCKs in the cardiovascular systemKensuke Noma, Naotsugu Oyama, James K LiaoFASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 29, 2012
FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2Ryuji Okamoto, Yuxin Li, Kensuke Noma, et al.Circulation|November 2, 2005
Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient miceYoshiyuki Rikitake, Naotsugu Oyama, Chao-Yung C Wang, et al.Circulation Research|November 11, 2006
Rho kinase inhibition improves endothelial function in human subjects with coronary artery diseaseAnju Nohria, Matthew E Grunert, Yoshiyuki Rikitake, et al.Expert Opinion on Pharmacotherapy|September 14, 2018
Cilostazol for treatment of cerebral infarctionKensuke Noma, Yukihito HigashiStroke|September 6, 2005
Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protectionYoshiyuki Rikitake, Hyung-Hwan Kim, Zhihong Huang, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 9, 2010
Increased leukocyte rho kinase (ROCK) activity and endothelial dysfunction in cigarette smokersTakayuki Hidaka, Takaki Hata, Junko Soga, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 6, 2015
Exogenous nitric oxide inhibits Rho-associated kinase activity in patients with angina pectoris: a randomized controlled trialTatsuya Maruhashi, Kensuke Noma, Noritaka Fujimura, et al.Journal of Cardiology|May 22, 2012
Striking crosstalk of ROCK signaling with endothelial functionKensuke Noma, Yasuki Kihara, Yukihito HigashiPageof 28